Proteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Navigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Enhancing IgAN Care: The Importance of a Proactive Approach
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Early Kidney Stress Signals: Risk Assessment Imperatives
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Jean Francis, MD
PeerIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know
How the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia
Advancing the Science of Anemia Due to CKD
The Pathophysiology of Anemia of CKD
Steven Fishbane, MD
Peer